March 26, 2024 C-Path Launches Consortium for Alpha-1 Antitrypsin Deficiency TUCSON, Ariz., March 26, 2024 — Critical Path Institute (C-Path) is excited to announce the launch of the Critical Path for Alph
March 25, 2024 C-Path to Spearhead New Task Force Dedicated to Accelerating Drug Development for Progressive Supranuclear Palsy Critical Path Institute (C-Path) today announced the formation of a new task force...
March 8, 2024 Rare Neurodegenerative Disease Efforts Under the ACT for ALS In this webinar from The Critical Path Institute’s Rare and Orphan Disease Program CP-RND consortium, members discuss in-dep
March 15, 2024 C-Path’s CURE Drug Repurposing Collaboratory Aims to Document 1,000 Cases on the CURE ID App for Long COVID Awareness Day TUCSON, Ariz., March 15, 2024 — Critical Path Institute’s (C-Path) CURE Drug Repurposing Collaboratory (CDRC), a leading advoc
March 5, 2024 C-Path Wraps Up Productive Leadership Retreat, In-Person Meetings Critical Path Institute proudly recruits elite talent from across the globe, supporting remote work and a healthy work-life balanc
January 16, 2024 C-Path weighs in on key topics to advance Real-World Data and Artificial Intelligence in Rare Diseases Vice President, Cécile Ollivier, serves on a panel of distinguished experts in the EJP RD-EFPIA Joint Advanced Webinar on...
February 15, 2024 C-Path Launches Revamped Website to Enhance Collaborations in Drug Development Critical Path Institute (C-Path) today officially launched its newly revamped website, designed to further enhance collab...
February 7, 2024 Dr. Janet Woodcock: A Visionary Leader in Regulatory Science and the Inspirational Force behind the Creation of Critical Path Institute In her nearly four decades with the U.S. Food and Drug Administration, Dr. Janet Woodcock personally transformed the culture of...
February 15, 2024 RDCA-DAP Webinar Aims to Increase Your Understanding of Disease Progression Models Join us Thursday, February 15, for Understanding disease progression models: What are they, why are they useful, and how are...